IL268970B2
Oral transmucosal formulations of substituted heterocycle fused gamma carbolines
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority and filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO2011133224A1 | Cites | World Intellectual Property Organization (WIPO) | XY | Search report | 1-8,14,17-18,20 |
| WO2015085004A1 | Cites | World Intellectual Property Organization (WIPO) | XY | Search report | 1-8,14,17-18,20 |
| MADHAV NVS ET AL., OROTRANSMUCOSAL DRUG DELIVERY SYSTEMS: A REVIEW, 6 August 2009 (2009-08-06) | Non-patent | – | – | Search report | – |
50 members in 12 offices
Members50
| Document | Office | Kind | |
|---|---|---|---|
| CA3054841A1 | Canada | A1 | |
| US2018271862A1 | United States of America | A1 | |
| WO2018175969A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2018240540A1 | Australia | A1 | |
| IL268970A | Israel | A | |
| IL268970D0 | Israel | D0 | |
| CN110430879A | China | A | |
| KR20190132671A | Republic of Korea | A | |
| MX2019011329A | Mexico | A | |
| EP3600325A1 | European Patent Office (EPO) | A1 | |
| BR112019019875A2 | Brazil | A2 | |
| JP2020512328A | Japan | A | |
| US10716786B2 | United States of America | B2 | |
| US2020375988A1 | United States of America | A1 | |
| EP3600325A4 | European Patent Office (EPO) | A4 | |
| RU2019133676A | Russian Federation | A | |
| US11052083B2 | United States of America | B2 | |
| RU2019133676A3 | Russian Federation | A3 | |
| AU2018240540B2 | Australia | B2 | |
| MX387784B | Mexico | B | |
| US2021361648A1 | United States of America | A1 | |
| AU2021286423A1 | Australia | A1 | |
| RU2767410C2 | Russian Federation | C2 | |
| RU2022103663A | Russian Federation | A | |
| KR102398194B1 | Republic of Korea | B1 | |
| KR20220066988A | Republic of Korea | A | |
| JP2022084651A | Japan | A | |
| MX2021013640A | Mexico | A | |
| MX395214B | Mexico | B | |
| JP7132939B2 | Japan | B2 | |
| MX2022010797A | Mexico | A | |
| CN110430879B | China | B | |
| CN116327770A | China | A | |
| AU2021286423B2 | Australia | B2 | |
| IL268970B1 | Israel | B1 | |
| IL304026A | Israel | A | |
| US2023301995A1 | United States of America | A1 | |
| US11806347B2 | United States of America | B2 | |
| IL268970B2This record | Israel | B2 | |
| US2024016802A1 | United States of America | A1 | |
| IL304026B1 | Israel | B1 | |
| KR102708440B1 | Republic of Korea | B1 | |
| KR20240141212A | Republic of Korea | A | |
| IL304026B2 | Israel | B2 | |
| MX387784B | Mexico | B | |
| MX395214B | Mexico | B | |
| US12268686B2 | United States of America | B2 | |
| US12336989B2 | United States of America | B2 | |
| US2025275962A1 | United States of America | A1 | |
| CN116327770B | China | B |
Numbers
- Publication
- 268970
- Application
- 268970
Titles2
- English
- ORAL TRANSMUCOSAL FORMULATIONS OF SUBSTITUTED HETEROCYCLE FUSED GAMMA CARBOLINES
- Hebrew
- תכשירים פומיים של תולדות גאמא קרבולינים הטרוציקליים מאוחים לספיגה דרך ריריות
Classification
- CPC, 25
- A61K31/4985
- A61K9/0036
- A61P3/04
- A61K9/06
- A61P1/14
- A61K9/0043
- A61P25/24
- A61K9/006
- A61P25/22
- A61K9/0019
- A61P25/18
- A61K9/14
- A61P15/08
- A61P25/06
- A61P25/00
- A61P25/28
- A61P25/16
- A61P25/04
- A61K47/38
- A61K47/36
- A61K47/42
- A61K47/32
- A61K9/0021
- A61K9/0034
- A61P25/20
- IPC, 4
- A61K31 4985
- A61K9 14
- A61K9 00
- A61K9 06